Womens Support Plus
Natural health product licensed in Canada
- Other names
- Physicians Research
- Licence holder
- Natural Professional Therapeutics Inc.
- NPN or DIN-HM
- 80040307
- Status
- Active licence
- Licence date
- 25 February 2013
- Revision date
- 11 February 2025
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gamma-oryzanol Source : Gamma-oryzanol | 60 milligramme | Not calculated |
| Gamma-oryzanol Source : Oryza sativa - seed bran | 60 milligramme | Not calculated |
| Picea abies Source : Écorce (branche) | 25 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Eau purifiée, Cellulose microcristalline, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Womens Support helps to relieve symptoms associated with menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not take if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner. Do not expose yourself to sources of ultraviolet rays (e.g. the sun & tanning salons) for prolonged periods.
- Précautions et mises en garde
Consult a health care practitioner prior to use if symptoms persist worsen or a skin rash develops. Consult a health care practitioner prior to use if you have diabetes, a liver disorder or develop symptoms of liver trouble. Consult a health care practitioner if you are taking blood thinners or other prescription medication. Consult a health care practitioner prior to use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy. Consult a health care practitioner prior to use if you have or are pre-disposed to cancer. Consult a health care practitioner prior to use if you are taking birth control pills. Discontinue use and consult a health care practitioner if you experience breast pain discomfort and/or tenderness.
Source
Official Health Canada record, licence 80040307
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.